Opthea Ltd: Opthea to participate in UBS Virtual Ophthalmology Day 2024
Opthea Ltd: Opthea Joins the S&P/ASX 300 Index
Opthea Ltd: Opthea Announces Completion of Drug Substance Campaign
Opthea Ltd: Opthea Presents at the 24th EURETINA Congress
Opthea Ltd: Opthea Announces Executive Leadership Changes & Senior Hires
Opthea Ltd: Opthea presents at H.C.Wainwright 26th Investment Conference
Opthea Ltd: Opthea 2024 Corporate Governance Statement
Opthea Ltd: Opthea to Participate in H.C Wainwright Virtual Conference
Opthea Ltd: Updated Quarterly Report and Cashflow
Opthea Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Opthea Ltd: Opthea Welcomes Retina Leaders to its Medical Advisory Board
Opthea Ltd: Security Class Reinstatement to Quotation- OPTOB
Opthea Ltd: OPTOB Top Holders
Opthea Ltd: OPTOB - Range of Units
Opthea Ltd: Security Class Suspension from Quotation OPTOB
Opthea Ltd: Opthea Announces Publication on VEGF- C and D
Opthea Ltd: Trading Halt - Accelerated Offer
Opthea Ltd: Trading Halt
Opthea Ltd: Opthea to Present at Clinical Trials at the Summit Meeting
Opthea Ltd: Opthea Completes Enrollment in Phase 3 Clinical Program
No Data
No Data